Patent · US Expired

Interleukin-1β converting enzyme inhibitors

US7138395B2 · kind B2 · utility

1Cited by
4References
69Claims
0Family size

Assignee

Inventors

Key dates

Filing dateJun 9, 2003
Grant dateNov 21, 2006
Priority date
Expiry dateNov 21, 2023

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07D487/04
  • WIPO fieldOrganic fine chemistry
  • WIPO sectorChemistry

Abstract

The present invention relates to novel compounds, compositions comprising said compounds, and uses thereof, said compounds having the formula:

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.